GlaxoSmithKline S.A.E Balance Sheet

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	479.69	75.47	829.34	585.85	73.57
Cash & Short-Term Investments	479.69	75.47	829.34	585.85	73.57
Cash Growth	535.59%	-90.90%	41.56%	696.36%	232.01%
Accounts Receivable	768.37	803.28	685.96	424.68	253.94
Other Receivables	3	50.34	23.89	318.64	408.81
Receivables	1,693	1,844	1,176	1,165	830.42
Inventory	1,419	945.21	695.27	485.89	500.45
Prepaid Expenses	-	-	-	-	17.58
Other Current Assets	-	-	164.7	216.65	126.47
Total Current Assets	3,592	2,865	2,866	2,454	1,548
Property, Plant & Equipment	756.84	641.17	572.14	548.11	540.21
Long-Term Investments	42.63	7.34	6.34	24.45	12.3
Goodwill	-	-	-	137.65	238.65
Long-Term Deferred Tax Assets	-	23.33	17.43	-	-
Other Long-Term Assets	109.97	115.83	96.48	21.33	85.09
Total Assets	4,501	3,653	3,558	3,185	2,425
Accounts Payable	1,023	486.93	524.53	176.8	104.54
Accrued Expenses	684.14	577.83	524.12	304.51	581.22
Short-Term Debt	-	-	-	-	118.21
Current Portion of Leases	43.79	38.28	28.39	17.48	29.52
Current Income Taxes Payable	65.51	159.39	97.93	308.57	17.38
Other Current Liabilities	394.88	313.45	348.98	585.89	161.22
Total Current Liabilities	2,211	1,576	1,524	1,393	1,012
Long-Term Leases	37.97	81.2	68.63	52.07	32.24
Long-Term Deferred Tax Liabilities	34.43	-	-	11.31	22.46
Total Liabilities	2,284	1,657	1,593	1,457	1,067
Common Stock	835.14	835.14	835.14	835.14	835.14
Retained Earnings	1,382	1,160	1,130	892.71	522.24
Total Common Equity	2,217	1,995	1,965	1,728	1,357
Minority Interest	0.61	0.6	0.6	0.58	0.58
Shareholders' Equity	2,217	1,996	1,965	1,728	1,358
Total Liabilities & Equity	4,501	3,653	3,558	3,185	2,425
Total Debt	81.76	119.48	97.03	69.55	179.97
Net Cash (Debt)	397.93	-44.01	732.32	516.3	-106.41
Net Cash Growth	-	-	41.84%	-	-
Net Cash Per Share	4.76	-0.53	8.77	6.18	-1.27
Filing Date Shares Outstanding	83.51	83.51	83.51	83.51	83.51
Total Common Shares Outstanding	83.51	83.51	83.51	83.51	83.51
Working Capital	1,380	1,289	1,342	1,060	536.41
Book Value Per Share	26.54	23.89	23.53	20.69	16.25
Tangible Book Value	2,217	1,995	1,965	1,590	1,119
Tangible Book Value Per Share	26.54	23.89	23.53	19.04	13.40
Land	17.59	17.59	17.59	12.65	12.65
Buildings	65.48	74.34	83.47	97.81	97.81
Machinery	811.29	696.44	668.83	662.18	629.59
Construction In Progress	197.12	152.54	108.51	88.86	98.67
Leasehold Improvements	35.38	24.27	26.81	26.85	42.34

Source: S&P Global Market Intelligence. Standard template. Financial Sources.